Sign in
4

Changes in Ownership

Acrivon Therapeutics, Inc. Filed Acc 0000905148-25-003507

Options or other derivatives

  • Chief Medical Officer acquired 225,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Mirza Mansoor Raza · Chief Medical Officer

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2025-10-01 Grant or award : show line 1 in the form Stock Option (Right to Buy) +225,000 225,000 D
Loading xslF345X05/form4.xml…